Case 2, a 68-year-old male treated with 7 + 3 induction chemotherapy followed by HiDAC consolidation and midostaurin for FLT3-mutated AML, presented with relapsed MS in the form of a skin rash, most pronounced on the right anterior shoulder. Here, FLT3 is linked to myeloid sarcoma.